The Priority Review

Tag

Cardiovascular

1 story

Stories

  1. Clinical trials

    Asundexian after stroke: 384 of 6,162 had an ischemic stroke versus 518 of 6,165 on placebo

    In the 12,327-participant OCEANIC-STROKE trial, 384 of 6,162 on asundexian had an ischemic stroke versus 518 of 6,165 on placebo; ISTH major bleeding occurred in 117 versus 107. The record gives sites and sponsors the full Phase 3 numbers.